ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Impact of SGLT2 Inhibitors on Tumor Development Risk in Type 2 Diabetes: A Retrospective Cohort Study.

Yuzhe Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.